Goodwill of RECURSION PHARMACEUTICALS, INC. from 30 Jun 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
RECURSION PHARMACEUTICALS, INC. quarterly Goodwill in USD history and change rate from 30 Jun 2020 to 30 Sep 2025.
  • RECURSION PHARMACEUTICALS, INC. Goodwill for the quarter ending 30 Sep 2025 was $162,042,000, a 211% increase year-over-year.
Source SEC data
View on sec.gov
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Change (%)

RECURSION PHARMACEUTICALS, INC. Quarterly Goodwill (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $162,042,000 +$109,986,000 +211% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $164,270,000 +$112,214,000 +216% 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 $158,112,000 +$106,056,000 +204% 31 Mar 2025 10-Q 05 May 2025 2025 Q1
Q4 2024 $148,873,000 +$96,817,000 +186% 31 Dec 2024 10-Q 05 Nov 2025 2025 Q3
Q3 2024 $52,056,000 -$694,000 -1.3% 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 $52,056,000 -$8,460,000 -14% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $52,056,000 +$51,255,000 +6399% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $52,056,000 +$51,255,000 +6399% 31 Dec 2023 10-K 28 Feb 2025 2024 FY
Q3 2023 $52,750,000 +$51,949,000 +6486% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $60,516,000 +$59,715,000 +7455% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $801,000 $0 0% 31 Mar 2023 10-Q 08 May 2023 2023 Q1
Q4 2022 $801,000 $0 0% 31 Dec 2022 10-K 28 Feb 2025 2024 FY
Q3 2022 $801,000 $0 0% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 $801,000 $0 0% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $801,000 $0 0% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 $801,000 $0 0% 31 Dec 2021 10-K 27 Feb 2023 2022 FY
Q3 2021 $801,000 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 $801,000 +$801,000 30 Jun 2021 10-Q 13 Aug 2021 2021 Q2
Q1 2021 $801,000 31 Mar 2021 10-Q 12 May 2021 2021 Q1
Q4 2020 $801,000 31 Dec 2020 10-K 23 Mar 2022 2021 FY
Q2 2020 $0 30 Jun 2020 10-Q 13 Aug 2021 2021 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.